This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Harrell, J. C. Articles by Horwitz, K. B. Search for Related Content PubMed PubMed Citation Articles by Harrell, J. C. Articles by Horwitz, K. B.

Estrogen Receptor Positive Breast Cancer Metastasis: Altered Hormonal Sensitivity and Tumor Aggressiveness in Lymphatic Vessels and Lymph Nodes

Departments of ¹ Medicine, ² Pathology, and ³ Program in Reproductive Sciences, University of Colorado Health Sciences Center, Aurora, Colorado; and ⁴ Breast Center, Baylor College of Medicine, Houston, Texas

Requests for reprints: Joshua Chuck Harrell, Department of Medicine/Endocrinology, University of Colorado Health Sciences Center, MS 8106, RC-1 South, Room 7402G, 12801 East 17th Avenue, P.O. Box 6511, Aurora, CO 80045. Phone: 303-724-3942; Fax: 303-724-3920; E-mail: joshua.harrell{at}uchsc.edu.

Breast cancers commonly spread to lymph nodes (LNs). If the primary tumors are estrogen receptor (ER) and/or progesterone receptor (PR) positive, then the likelihood that LN metastases express receptors exceeds 80%. However, due to lack of ER+ models, little is known about the role of hormones in breast cancer spread or the effects of the LN microenvironment on hormone responsiveness. We have developed metastasis models using ZsGreen labeled MCF-7 and T47D human breast cancer cells. Tumors are tracked in living mice by whole-body imaging, and macrometastases or micrometastases are detected by intravital imaging or fluorescence microscopy. Tumor growth is estrogen dependent and required for intratumoral lymphangiogenesis. Seventy-five percent of all tumors and >95% of larger tumors generate LN metastases. Occasionally more distant metastases are also observed. "Triads" of primary tumors, tumor-filled draining lymphatic vessels, and tumor-filled LNs from the same mouse show that (a) proliferation, as measured by 5-bromo-2'-deoxyuridine uptake, is higher in the LN than in the primary tumor. (b) High ER levels are extensively down-regulated by estradiol in primary tumors. However, there is partial failure of ER down-regulation in LNs associated with (c) reduced PR expression. This suggests that ER are dysfunctional in the LN microenvironment and perhaps hormone resistant. (d) CD44 is sparsely expressed in primary tumor cells but homogeneously overexpressed in cells transiting the lymphatics and populating LNs. We hypothesize that CD44 expression targets tumor cells for transport to, and uptake in, LNs. If so, the CD44 pathway could be targeted therapeutically to slow or prevent LN metastases. (Cancer Res 2006; 66(18): 9308-15)

This article has been cited by other articles:

				J. Zheng, J. E. Koblinski, L. V. Dutson, Y. B. Feeney, and C. V. Clevenger Prolyl Isomerase Cyclophilin A Regulation of Janus-Activated Kinase 2 and the Progression of Human Breast Cancer Cancer Res., October 1, 2008; 68(19): 7769 - 7778. [Abstract] [Full Text] [PDF]

				A. Boulay, M. Breuleux, C. Stephan, C. Fux, C. Brisken, M. Fiche, M. Wartmann, M. Stumm, H. A. Lane, and N. E. Hynes The Ret Receptor Tyrosine Kinase Pathway Functionally Interacts with the ER{alpha} Pathway in Breast Cancer Cancer Res., May 15, 2008; 68(10): 3743 - 3751. [Abstract] [Full Text] [PDF]

				K. B. Horwitz, W. W. Dye, J. C. Harrell, P. Kabos, and C. A. Sartorius Rare steroid receptor-negative basal-like tumorigenic cells in luminal subtype human breast cancer xenografts PNAS, April 15, 2008; 105(15): 5774 - 5779. [Abstract] [Full Text] [PDF]

				R. D. Coletta, K. L. Christensen, D. S. Micalizzi, P. Jedlicka, M. Varella-Garcia, and H. L. Ford Six1 Overexpression in Mammary Cells Induces Genomic Instability and Is Sufficient for Malignant Transformation Cancer Res., April 1, 2008; 68(7): 2204 - 2213. [Abstract] [Full Text] [PDF]

				J. C. Harrell, W. W. Dye, D. M.E. Harvell, M. Pinto, P. Jedlicka, C. A. Sartorius, and K. B. Horwitz Estrogen Insensitivity in a Model of Estrogen Receptor Positive Breast Cancer Lymph Node Metastasis Cancer Res., November 1, 2007; 67(21): 10582 - 10591. [Abstract] [Full Text] [PDF]